Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression
about
Roles of the (pro)renin receptor in the kidneyLipid mediators are critical in resolving inflammation: a review of the emerging roles of eicosanoids in diabetes mellitusCrosstalk between (Pro)renin receptor and COX-2 in the renal medulla during angiotensin II-induced hypertensionIndomethacin reduces glomerular and tubular damage markers but not renal inflammation in chronic kidney disease patients: a post-hoc analysisInteraction of the renin angiotensin and cox systems in the kidney.(Pro)renin receptor regulates autophagy and apoptosis in podocytes exposed to high glucose.High glucose induces podocyte injury via enhanced (pro)renin receptor-Wnt-β-catenin-snail signaling pathway.EP4 inhibition attenuates the development of diabetic and non-diabetic experimental kidney disease.The role of microRNAs in diabetic nephropathy.Receptor activator of NF-kappaB and podocytes: towards a function of a novel receptor-ligand pair in the survival response of podocyte injury.Albumin-induced podocyte injury and protection are associated with regulation of COX-2.Role of COX-2/mPGES-1/prostaglandin E2 cascade in kidney injury.The (pro)renin receptor. A decade of research: what have we learned?The Protective Effect of Beraprost Sodium on Diabetic Nephropathy by Inhibiting Inflammation and p38 MAPK Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Rats.Beneficial Effect of 7-O-Galloyl-D-sedoheptulose, a Polyphenol Isolated from Corni Fructus, against Diabetes-Induced Alterations in Kidney and Adipose Tissue of Type 2 Diabetic db/db MiceNew Insights into the PPAR γ Agonists for the Treatment of Diabetic Nephropathy.The intracrine renin-angiotensin system.Key developments in renin-angiotensin-aldosterone system inhibition.Renin inhibition in the treatment of diabetic kidney disease.Chinese prescription Kangen-karyu and Salviae Miltiorrhizae Radix improve age-related oxidative stress and inflammatory response through the PI3K/Akt or MAPK pathways.Direct renin inhibition prevents cardiac dysfunction in a diabetic mouse model: comparison with an angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor(Pro)renin receptor activation increases profibrotic markers and fibroblast-like phenotype through MAPK-dependent ROS formation in mouse renal collecting duct cells.Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease.Kidney proximal tubular epithelial-specific overexpression of netrin-1 suppresses inflammation and albuminuria through suppression of COX-2-mediated PGE2 production in streptozotocin-induced diabetic mice.Chronic administration of EP4-selective agonist exacerbates albuminuria and fibrosis of the kidney in streptozotocin-induced diabetic mice through IL-6.Functional intracellular renin-angiotensin systems: potential for pathophysiology of diseaseCelecoxib modifies glomerular basement membrane, mesangium and podocytes in OVE26 mice, but ibuprofen is more detrimental.Heat-Processed Scutellariae Radix Protects Hepatic Inflammation through the Amelioration of Oxidative Stress in Lipopolysaccharide-Induced Mice.Protective Effect of Safflower Seed on Cisplatin-Induced Renal Damage in Mice via Oxidative Stress and Apoptosis-Mediated Pathways.Pharmacological and Genetic Inhibition of Downstream Targets of p38 MAPK in Experimental Nephrotic Syndrome.Transforming growth factor-β1 and phosphatases modulate COX-2 protein expression and TAU phosphorylation in cultured immortalized podocytes.Effect of the oral iron chelator deferiprone in diabetic nephropathy rats.7-O-galloyl-D-sedoheptulose ameliorates renal damage triggered by reactive oxygen species-sensitive pathway of inflammation and apoptosis.Prostaglandins in the pathogenesis of kidney diseases.
P2860
Q27026784-D802C8D5-CA0A-4115-80E8-B1F137526295Q28080521-1C473DF6-B30B-4A38-9238-AC71FC08EB9DQ28081721-87F58DD6-2C62-45CE-8865-946EE48EF3CAQ28729196-757BE68F-CF1D-44DE-84F0-BBD0E882B735Q30276943-358C2588-2E7A-4E72-8E94-DADD6EE2AD46Q30279173-9C0D2CE6-9687-4872-A597-57F64DE4F178Q30414788-9451CE8A-77F7-4265-845F-A0D518537CD2Q33794256-6F093068-5A55-4EBD-8244-0E1E733F3696Q34195411-8E1F8077-88D6-4D1B-B4F4-0D4AE9513724Q34358320-049492D9-E8B6-405D-AF7B-564E77FD3303Q34577309-F0BBF7E1-48B8-4DA9-84CF-31983EE3A105Q35097808-418D25C8-F3B1-4223-AF76-6DA7DB5BA8DDQ36557476-F8CEAF99-14CD-4A8F-A5DA-ADB21B09E49CQ36880835-2CA69174-8FCA-4215-BE2B-101DD3AB3C10Q37368760-F49D9141-4821-4785-9C1A-3B8F1FAAA1B6Q37590946-38BADEBA-F9F1-45B5-B014-534205CC1AC9Q38010459-22CEB37C-5973-4F25-B811-C44CCD75E9B0Q38061004-320BF4C3-816D-4DF2-BF01-BEF83BC97E6AQ38075571-A261503E-1B19-4CED-8780-05A707C83382Q38436450-A9AB2697-7344-435F-934D-1C242198541EQ38691518-F032D7AB-616A-440D-8840-5A96A48C4C63Q38697570-41501DCA-0787-4583-93D7-C0C4B6F114FFQ38793769-8B39F5D3-F541-4579-94C4-D60D8A88C458Q39264836-E56D33A9-5920-4C35-8645-BBC7562DB084Q41987509-B0C20F39-DD5C-47CE-B24E-C5F704D9357EQ42570286-E5687043-1E7E-4031-B181-B4B86FD9929FQ44016944-A2595655-EA54-4055-AA21-917CBB46532BQ46317839-68EEDC97-89F2-47B5-A4BE-ADAB3A2ACDB5Q47202361-24115884-3ECA-428A-B003-C4415BD33BCBQ47350783-310CE4E0-C63D-48AE-82DF-59F13D8514D2Q47585220-95B2CB81-69DF-4936-83C8-C1F3A3F42490Q53113273-9C0E36E2-BEA6-418A-8EA6-9672C279BB31Q53354020-B3C767DC-5E03-44D1-8D19-3F07891C14E1Q55399934-1DBF5C58-6896-41E3-B204-89E7045C23B0
P2860
Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Podocyte COX-2 exacerbates dia ...... (pro)renin receptor expression
@en
type
label
Podocyte COX-2 exacerbates dia ...... (pro)renin receptor expression
@en
prefLabel
Podocyte COX-2 exacerbates dia ...... (pro)renin receptor expression
@en
P2093
P2860
P356
P1476
Podocyte COX-2 exacerbates dia ...... (pro)renin receptor expression
@en
P2093
Gilbert W Moeckel
Huifang Cheng
Raymond C Harris
Xiaofeng Fan
P2860
P304
P356
10.1681/ASN.2010111149
P577
2011-07-01T00:00:00Z